Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$26,849
-$51,466 QoQ
Shares Held
1,115
-60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,678
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEEDER ASSET MANAGEMENT INC holds $140,500,918 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,922 | $34,689,912 | |
| 2 | JNJ |
Johnson & Johnson
|
117,192 | $29,763,248 | |
| 3 | ABBV |
AbbVie Inc.
|
98,512 | $24,789,557 | |
| 4 | AMGN |
Amgen Inc
|
65,451 | $23,701,113 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
135,547 | $17,125,003 | |
| 6 | MRK |
Merck & Co., Inc.
|
71,755 | $9,220,516 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
20,426 | $1,176,942 | |
| 8 | PFE |
Pfizer Inc
This page
|
1,115 | $26,849 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,849 | 1,115 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $78,315 | 2,789 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $30,079 | 1,208 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $31,416 | 1,233 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $30,566 | 1,261 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $25,618 | 1,011 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $41,041 | 1,547 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $45,754 | 1,581 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $141,606 | 5,061 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,516,176 | 54,637 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $1,547,635 | 53,756 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,494,634 | 135,503 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,954,734 | 135,080 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,505,263 | 134,933 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,038,168 | 137,357 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,770,376 | 200,420 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,622,786 | 202,609 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $10,299,586 | 198,949 | Shares | Defined | 2022-05-10 | |
| 2021-09-30 | $12,137,332 | 282,198 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $10,940,638 | 279,383 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $9,942,486 | 274,427 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $1,400,105 | 38,036 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $9,705,595 | 264,458 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $8,487,060 | 259,543 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $8,303,111 | 254,385 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||